Assignee
SYNTIS BIO INC
US·3 granted patents·3 pending applications·2 citations·filing 2021–2024
Top patents by PatentIndex Score
6 records- 0187US12241100B2Engineered leucine decarboxylasesSYNTIS BIO INC·Filed 2021·Granted Mar 4, 2025·2 cites·6 claims
- 0271US2025101401A1Engineered methionine gamma lyase variantsSYNTIS BIO INC·Filed 2024·Application pending·0 cites
- 0366US12110521B2Engineered methionine gamma lyase variantsSYNTIS BIO INC·Filed 2022·Granted Oct 8, 2024·0 cites·24 claims
- 0462US2024261411A1Permeation enhancers for gastrointestinal synthetic epithelial liningsSYNTIS BIO INC·Filed 2024·Application pending·0 cites
- 0560US12502421B2Engineered leucine decarboxylasesSYNTIS BIO INC·Filed 2022·Granted Dec 23, 2025·0 cites·20 claims
- 0643US2025206773A1Forms and compositions of sodium chenodeoxycholateSYNTIS BIO INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SYNTIS BIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →